Loading...

Innovative Eyewear, Inc.

LUCYNASDAQ
Healthcare
Medical - Instruments & Supplies
$1.98
$-0.01(-0.50%)

Innovative Eyewear, Inc. (LUCY) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Innovative Eyewear, Inc. (LUCY), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
141893.04%
141893.04%
Operating Income Growth
-34263.62%
34263.62%
Net Income Growth
-116454.35%
116454.35%
Operating Cash Flow Growth
-116779.57%
116779.57%
Operating Margin
-1.76%
1.76%
Gross Margin
48.39%
48.39%
Net Profit Margin
-391.35%
391.35%
ROE
-18399.78%
18399.78%
ROIC
-70.70%
70.70%

Innovative Eyewear, Inc. (LUCY) Income Statement & Financial Overview

Explore comprehensive income reports for Innovative Eyewear, Inc. LUCY, broken down by year and quarter.

MetricQ3 2024Q2 2024Q1 2024Q4 2023
Revenue$253599.00$308682.00$383471.00$615754.00
Cost of Revenue$194255.00$253506.00$376520.00$795902.00
Gross Profit$59344.00$55176.00$6951.00-$180148.00
Gross Profit Ratio$0.23$0.18$0.02-$0.29
R&D Expenses$131369.00$256802.00$216301.00$120836.00
SG&A Expenses$1.66M$1.74M$447651.00$2.19M
Operating Expenses$59344.00$2.03M$663952.00$2.32M
Total Costs & Expenses$253599.00$2.28M$1.04M$3.11M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$33858.00$45775.00$29473.00$19231.00
EBITDA-$1.69M-$1.90M-$1.94M-$2.37M
EBITDA Ratio-$6.65-$6.16-$1.71-$4.02
Operating Income-$1.76M$0.00-$657001.00-$2.50M
Operating Income Ratio-$6.95$0.00-$1.71-$4.05
Other Income/Expenses (Net)$41386.00-$1.95M$43279.00$146797.00
Income Before Tax-$1.72M-$1.95M-$1.97M-$2.39M
Income Before Tax Ratio-$6.79-$6.31-$5.14-$3.89
Income Tax Expense$1.72B$0.00-$29473.00-$1.00
Net Income-$1.72B-$1.95M-$1.97M-$2.39M
Net Income Ratio-$6785.03-$6.31-$5.14-$3.89
EPS-$990.72-$1.87-$3.04-$3.70
Diluted EPS-$990.72-$1.87-$3.04-$3.70
Weighted Avg Shares Outstanding$1.74M$1.04M$647605.00$647441.00
Weighted Avg Shares Outstanding (Diluted)$1.74M$1.04M$647605.00$647441.00

The company's financials show resilient growth, with revenue advancing from $615754.00 in Q4 2023 to $253599.00 in Q3 2024. Gross profit remained healthy with margins at 23% in Q3 2024 compared to -29% in Q4 2023. Operating income hit -$1.76M last quarter, sustaining a consistent -695% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$1.69M. Net income dropped to -$1.72B, while earnings per share reached -$990.72. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;